asfotase alfa Injection

Brand(s)
Strensiq
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Alexion Pharmaceuticals Inc. (2015-10-29)
Oldest Current Product
2015-10-23
License(s)
BLA
RxNORM
INJECTION\ASFOTASE ALFA
SPL Active
SUBCUTANEOUS\SOLUTION\ASFOTASE ALFA
SPL Moiety
SUBCUTANEOUS\SOLUTION\ASFOTASE ALFA

product(s) by strength(s)

0.8 ml asfotase alfa 100 mg/ml injection

product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1256820019StrensiqBLAAlexion Pharmaceuticals Inc.2015-10-23ASFOTASE ALFASUBCUTANEOUSSOLUTION1255133387574f-5eaa-4501-a71d-4cbfbd563031

1 ml asfotase alfa 40 mg/ml injection

product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1256820016StrensiqBLAAlexion Pharmaceuticals Inc.2015-10-23ASFOTASE ALFASUBCUTANEOUSSOLUTION1255133387574f-5eaa-4501-a71d-4cbfbd563031

0.7 ml asfotase alfa 40 mg/ml injection

product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1256820013StrensiqBLAAlexion Pharmaceuticals Inc.2015-10-23ASFOTASE ALFASUBCUTANEOUSSOLUTION1255133387574f-5eaa-4501-a71d-4cbfbd563031

0.45 ml asfotase alfa 40 mg/ml injection

product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1256820010StrensiqBLAAlexion Pharmaceuticals Inc.2015-10-23ASFOTASE ALFASUBCUTANEOUSSOLUTION1255133387574f-5eaa-4501-a71d-4cbfbd563031

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
13387574f-5eaa-4501-a71d-4cbfbd563031 (view SPL)These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ (asfotase alfa) injection, for subcutaneous useInitial U.S. Approval: 2015prescriptionHuman PrescriptionAlexion Pharmaceuticals Inc.2015-10-298256820010, 256820013, 256820016, 256820019

Data from: LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII